NASDAQ : VYNE

VYNE Therapeutics Inc.

$0.761 USD

-$0.01 (-0.85%)

Volume
1.01M
Average Volume
534.06K
Market Capitalization
$12.68M
P/E Ratio
-1.57
Dividend Yield
0.00%
Price Target
$5.75
Year High
$1.60
Year Low
$0.28
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$20.86
Source Headline
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share

globenewswire.com - 2026-07-10 08:00:00

Get VYNE Insider Trade Alerts

VYNE Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$5.75

1 analysts

VYNE Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-07-30 HC Wainwright & Co. Downgrade Buy Neutral
2025-04-25 HC Wainwright & Co. Maintain Buy Buy
2025-03-06 HC Wainwright & Co. Maintain Buy Buy
2025-02-19 HC Wainwright & Co. Maintain Buy Buy
2025-01-14 HC Wainwright & Co. Maintain Buy Buy
2025-01-06 HC Wainwright & Co. Maintain Buy Buy
2024-12-23 HC Wainwright & Co. Maintain Buy Buy
2024-11-08 HC Wainwright & Co. Maintain Buy Buy
2024-09-12 HC Wainwright & Co. Maintain Buy Buy
2024-08-15 HC Wainwright & Co. Maintain Buy Buy
2024-06-14 HC Wainwright & Co. Maintain Buy Buy
2024-06-05 HC Wainwright & Co. Maintain Buy Buy
2024-05-09 HC Wainwright & Co. Maintain Buy Buy
2024-05-06 HC Wainwright & Co. Maintain Buy Buy
2024-02-29 HC Wainwright & Co. Maintain Buy Buy
2023-10-30 HC Wainwright & Co. Maintain Buy Buy
2023-08-14 HC Wainwright & Co. Maintain Buy Buy
2023-05-12 Cantor Fitzgerald Maintain Overweight Overweight
2023-05-12 HC Wainwright & Co. Maintain Buy Buy
2022-08-10 HC Wainwright & Co. Maintain Buy Buy
2021-05-07 HC Wainwright & Co. Maintain Buy Buy